Argenx to report first quarter 2025 financial results and business update on may 8, 2025

May 1, 2025 amsterdam, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on thursday, may 8, 2025 at 2:30 p.m. cet (8:30 a.m. et) to discuss its first quarter 2025 financial results and provide a business update.
ARGX Ratings Summary
ARGX Quant Ranking